From: Extended dosing of darbepoetin alfa in peritoneal dialysis patients
n (%) | |
---|---|
Eligible subjects (full analysis set) | 741 |
Subjects who completed study | 640 (86.4) |
Subjects who discontinued study | 101 (13.6) |
Kidney transplant | 39 (38.6)a |
Death | 36 (35.6)a |
No longer treated at clinic | 15 (14.9)a |
Consent withdrawn | 1 (1.0)a |
Other | 10 (9.9)a |